Navigation Links
Massachusetts General Hospital Center Reignites Methods in Bioengineering Conference
Date:4/6/2011

BOSTON, April 6, 2011 /PRNewswire/ -- The Center for Engineering in Medicine (CEM) -- a bioengineering research institute at the Massachusetts General Hospital (MGH), a Harvard Teaching Hospital -- has announced it will reconvene its popular "Methods in Bioengineering" conference in conjunction with event organizer Horizon House Ltd.  The event, BioMethods Boston, will take place at Harvard Medical School on July 14-15, and expects to draw over 400 senior researchers from the Boston biotech community.

BioMethods Boston has confirmed program participation from Harvard, MIT, Boston University, Northeastern, WPI, and Tufts, plus top-tier pharma companies like Millipore, Life Technologies, and Genzyme, as well as major health centers like Mass General Hospital and Children's Hospital Boston.

BioMethods Boston’s agenda will include sessions on stem cell therapies, functional imaging, BioMEMS, nanotechnologies, and gene delivery. A call for posters has just been announced, and an automated interface for submissions, as well as the nearly-complete agenda, can be accessed at the event website (www.biomethodsboston.com). "This event is designed to give biomedical investigators from all fields a clear perspective on the most advanced technologies, techniques, and methodologies, and an opportunity for attendees to network with top researchers in the field," says Dr. Martin Yarmush, Director of the CEM.

Yarmush is joined on the program committee by Dr. Robert Langer of MIT, named by Forbes' magazine as one of the 25 most important people in biotechnology, as well as Dr. James Burns, SVP, Drug & Biomaterial R&D at Genzyme Corp., Dr. Donald Ingber, Director, Wyss Institute for Biologically Inspired Engineering at Harvard, Dr. Joachim Kohn, Director, New Jersey Center for Biomaterials at Rutgers, Dr. Mehmet Toner, Director, BioMEMS Resource Center at MGH, Dr. Kyongbum Lee, Department Chair, C
'/>"/>

SOURCE Horizon House Ltd.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related biology news :

1. Massachusetts General Hospitals Warren Triennial Prize to honor pioneers of cellular reprogramming
2. L-1 Identity Solutions Awarded New Massachusetts RMV Drivers License Contract Valued at an Estimated $32 Million
3. Boston Medical Center to receive $245,000 grant from Attorney General Martha Coakley
4. Entrust President and CEO Bill Conner Addresses Global Dignitaries During INTERPOL 79th General Assembly
5. General Manifolds LLC Announces Issuance of US Patent in Computational Neuroscience
6. Major moral decisions use general-purpose brain circuits to manage uncertainty
7. Mass. General researchers develop functional, transplantable rat liver grafts
8. Oil Refineries Announces Delay to Annual & Special General Meeting
9. American Society for Microbiology to host 110th general meeting in San Diego
10. Modern man found to be generally monogamous, moderately polygamous
11. HFSP President Arima and Secretary General Winnacker awarded for fostering cooperation with China
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/19/2014)...   LaunchKey , the first decentralized mobile authentication ... of Things era, today announced the close of $3 ... led by Metamorphic Ventures with participation from ENIAC Ventures, ... others.  LaunchKey has raised $4 million to date, and ... and bring LaunchKey to market in 2015. ...
(Date:12/17/2014)... Valencell, a leader in performance biometric data ... industry leaders such as Intel, Jabra, Atlas, and Scosche ... products. These products will be showcased at CES 2015, ... . "Our partners choose PerformTek ... – with the clinical data to back it up," ...
(Date:12/11/2014)... --Research and Markets , ... ) has announced the addition of the ... to their offering. One major ... technology. With continuous advances in technology, it is ... standard that meets the needs and expectations of ...
Breaking Biology News(10 mins):LaunchKey Raises $3 Million in Additional Funding Led by Metamorphic Ventures 2LaunchKey Raises $3 Million in Additional Funding Led by Metamorphic Ventures 3Valencell PerformTek Biometrics Power the Most Accurate Wearables at CES 2015 2Biometrics Market in the APAC Region 2015-2019: Key Vendors are 3M Cogent, NEC, Safran and Suprema 2
... release is available in French . ... action to better control the sale of chemicals that ... Lunn, Minister of Natural Resources, and the Honourable Stockwell ... regulations for these chemicals, known as explosives precursors, will ...
... American,Association of Airport Executives President Chip ... Traveler (RT) program with the opening of,RT ... Reagan,Washington National Airport., "The expansion of ... in,the nation,s capital will further highlight the ...
... — Robots are fluent in their native language of 1 ... imprecise nature of human language. While scientists are making slow, ... responds to speech, gestures and body language, a more straightforward ... homes sooner. A team of researchers led by Charlie ...
Cached Biology News:New regulations tighten controls on restricted chemicals 2AAAE Applauds Expansion of Registered Traveler Program to Nation's Capital 2AAAE Applauds Expansion of Registered Traveler Program to Nation's Capital 3Robot fetches objects with just a point and a click 2Robot fetches objects with just a point and a click 3Robot fetches objects with just a point and a click 4
(Date:12/22/2014)... 22, 2014 The American ... of original research, reviews and editorials addressing developments ... practice, today published a provocative article exploring the ... progression and potential treatment of prostate cancer. ... and proposes the possibility that there could be ...
(Date:12/22/2014)... 2014 Fertility Associates of Memphis has ... USA , a network of more than 20 contributing ... patients have fast access to a national pool of ... . Fertility Associates of Memphis is the only fertility ... option. , Dr. William Kutteh , director of ...
(Date:12/19/2014)... Charm Sciences is pleased to announce that ... Aflatoxin M1 in raw commingled milk is the first ... The peer reviewed report of the validation by Technology ... and Fisheries Research (ILVO-T&V) has been published by the ... most toxic aflatoxin and a known carcinogen, can be ...
(Date:12/19/2014)... 19, 2014 Naurex Inc., a biopharmaceutical company ... diseases of the central nervous system, today announced that ... officer, will present at the 33 rd annual ... place at 3:00 p.m. PST on Tuesday, January 13, ... San Francisco, Calif. About ...
Breaking Biology Technology:Prostate Cancer Experts Dissect the Role of Follicle-stimulating Hormone in the Development, Progression and Potential Treatment of Prostate Cancer 2Prostate Cancer Experts Dissect the Role of Follicle-stimulating Hormone in the Development, Progression and Potential Treatment of Prostate Cancer 3Prostate Cancer Experts Dissect the Role of Follicle-stimulating Hormone in the Development, Progression and Potential Treatment of Prostate Cancer 4Fertility Associates of Memphis Announces Partnership with Donor Egg Bank USA 2Fertility Associates of Memphis Announces Partnership with Donor Egg Bank USA 3Charm Sciences Achieves Independent Validation of First 15 Minute Quantitative Screening Method for Aflatoxin M1 2Naurex to Present at 33rd Annual J.P. Morgan Healthcare Conference 2
... , , BETHESDA, Md., July ... and NWBS) today announces that it will seek shareholder approval for ... AIM market ("AIM") (the "De-listing"). The Company plans to continue its ... Board Market ("U.S. listing"), and plans to file an S1 registration ...
... , SAN DIEGO, July 23 Anadys Pharmaceuticals, Inc. ... quarter 2009 financial results on Thursday, July 30, 2009, after the U.S. ... hold a conference call and webcast on Thursday, July 30, 2009 at ... results and highlights and to provide an update on its development programs. ...
... , SUNNYVALE, Calif., July 23 ... for the treatment of chronic total occlusions (CTOs), today announced the ... Chris previously held the position of Executive VP, Sales and Marketing ... Devices including the last 2 years at FlowCardia. , ...
Cached Biology Technology:Northwest Biotherapeutics Announces Plans to De-list From AIM and Consolidate its Stock Market Listing in U.S. 2Northwest Biotherapeutics Announces Plans to De-list From AIM and Consolidate its Stock Market Listing in U.S. 3Anadys Pharmaceuticals to Report Second Quarter 2009 Financial Results 2FlowCardia, Inc. Appoints Chris Barys to Chief Operating Officer 2
...
Request Info...
OmniSlide thermal Cycler for slide applications. 20 slide capacity. Humidity Chamber. Slide Rack can be transferred directly to Wash Module to avoid handling individual slides....
... effect inhibition assays, also known as CPE and ... supernatents; serum from PK studies and delivery formulations. ... as the quantity of interferon required per milliliter ... by 50%. All standards used in ...
Biology Products: